(Q33386650)

26 July 2017

title

Systemic sarcoidosis with bone marrow involvement responding to therapy with adalimumab: a case report (English)

1 reference

26 July 2017

0 references

Supen R Patel

1

1 reference

26 July 2017

language of work or name

English

0 references

publication date

29 July 2009

1 reference

Journal of Medical Case Reports

26 July 2017

published in

1 reference

26 July 2017

volume

3

1 reference

26 July 2017

page(s)

8573

1 reference

https://scigraph.springernature.com/pub.10.4076/1752-1947-3-8573

26 July 2017

exact match

0 references

cites work

Comparison of two adalimumab treatment schedule strategies for moderate-to-severe Crohn's disease: results from the CHARM trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

Adalimumab safety and mortality rates from global clinical trials of six immune-mediated inflammatory diseases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

Adalimumab therapy for moderate to severe psoriasis: A randomized, controlled phase III trial.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

Infliximab therapy in patients with chronic sarcoidosis and pulmonary involvement

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

Tumour necrosis factor alpha inhibitor treatment for sarcoidosis refractory to conventional treatments: a report of five patients

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

What is the future of methotrexate in sarcoidosis? A study and review

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

Differential diagnoses of bone marrow granuloma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

Treatment of therapy-resistant sarcoidosis with adalimumab.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

Treatment of sarcoidosis with infliximab

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

Successful tumor necrosis factor alpha blockade treatment in therapy-resistant sarcoidosis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

Refractory Sarcoidosis Responding to Infliximab *

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

Clinical characteristics of patients in a case control study of sarcoidosis

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2737791

Treatment of complicated sarcoidosis with infliximab anti-tumor necrosis factor-alpha therapy

31 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19830230

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Adalimumab for treatment of cutaneous sarcoidosis

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19830230

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Progressive cutaneous sarcoidosis responding to anti-tumor necrosis factor-alpha therapy

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/19830230

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.4076/1752-1947-3-8573

1 reference

Dimensions Publication ID

26 July 2017

1 reference

https://scigraph.springernature.com/pub.10.4076/1752-1947-3-8573

9 September 2019

1 reference

26 July 2017

1 reference